Pharma-Bio Serv PBSV Cash Flow Statement (2010-2026)

OTC PBSV
$0.54 +0.04 (+8.00%)
At close: Sep 4, 2026 · 4:00 PM EDT
Reported Financials

Pharma-Bio Serv Quarterly Cash Flow Statement

Periods 64 quarters
Latest Apr 2026

Pharma-Bio Serv reported cash from operations of -$0.37M and free cash flow of -$0.37M for the quarter ended Apr 2026, down 21.1% year over year. This cash flow statement covers 64 quarters of results from Jul 2010 through Apr 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jul2010 Oct2010 Jan2011 Apr2011 Jul2011 Oct2011 Jan2012 Apr2012 Jul2012 Oct2012 Jan2013 Apr2013 Jul2013 Oct2013 Jan2014 Apr2014 Jul2014 Oct2014 Jan2015 Apr2015 Jul2015 Oct2015 Jan2016 Apr2016 Jul2016 Oct2016 Jan2017 Apr2017 Jul2017 Oct2017 Jan2018 Apr2018 Jul2018 Oct2018 Jan2019 Apr2019 Jul2019 Oct2019 Jan2020 Apr2020 Jul2020 Oct2020 Jan2021 Apr2021 Jul2021 Oct2021 Jan2022 Apr2022 Jul2022 Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Jan2026 Apr2026
Operating Activities
Net Income
2.28M-4.87M0.31M0.24M0.29M0.17M0.43M0.40M0.53M-0.05M-0.27M-0.21M-0.31M0.02M0.01M0.10M-0.21M-102.000.03M0.23M
Share-based CompensationStock Comp.
-0.55M0.36M-0.15M-0.12M0.22M-0.42M0.01M0.01M0.01M684.000.01M-0.07M0.02M0.00M-0.04M-0.03M0.10M0.00M-0.04M0.01M
Cash from Discontinued OperationsCash from Discont. Ops
Gains from Investment SecuritiesGains Investment
Cash from OperationsCash from Ops.
0.44M0.96M-0.33M-0.45M1.11M0.26M0.88M-0.25M0.96M0.31M0.73M-0.70M-0.67M0.08M-0.43M-0.30M0.24M0.28M-0.39M-0.37M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.03M
Depreciation & Amortization (CF)Dep. & Amort.
0.02M0.01M0.01M0.01M0.01M0.01M0.02M0.01M0.01M0.01M0.01M0.01M0.00M0.01M0.01M0.02M0.02M0.02M0.01M0.01M
Change in Working Capital
Change in ReceivablesChange Receivables
0.28M0.47M0.45M0.46M0.65M-0.21M-0.74M0.66M0.38M-1.55M-1.56M0.21M-0.02M-0.09M0.19M-0.06M-0.68M0.35M0.28M0.08M
Change in InventoryChange Inventory
2.84M-6.18M7.33M-0.46M3.69M0.33M0.99M-3.22M2.76M-1.88M
Change in Accured ExpensesChange Accured Exp.
0.36M0.19M-0.37M-0.08M-0.08M-0.20M0.02M0.17M-0.32M-0.43M-0.38M-0.35M-0.05M-0.21M-0.60M-0.12M0.08M-0.15M-0.55M
Other Working Capital ChangesOther WC Changes
0.01M-0.04M
Investing Activities
Capital ExpendituresCapex
0.01M-881.00684.000.00M0.00M0.01M0.01M764.00-0.00M820.000.00M0.16M0.00M0.00M350.000.00M0.00M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.01M
Divestments
Cash from Investing ActivitiesCash from Investing
-0.01M881.00-684.00-0.00M-0.00M-0.01M-8.20M2.83M-6.18M7.33M-4.76M-0.46M3.69M0.17M0.99M-3.23M1.63M-0.86M2.77M-1.89M
Financing Activities
Other financing activitiesOther financing
3.005.001.00
Cash from Financing ActivitiesCash from Financing
0.04M-1.78M-1.74M-0.01M-0.00M-1.75M-0.01M-792.00-0.01M-1.72M-0.00M-1.74M-0.01M-0.01M-0.00M-1.72M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
0.08M0.14M0.08M0.09M0.08M
Net Equity Issued and RepurchasedNet Equity Issued
Dividend Payments
Dividends Paid - CommonDiv. Paid (Common)
1.72M1.72M1.72M1.72M1.72M-1.72M1.72M-1.72M1.72M
Additional items
Exchange Rate EffectFX Effect
-0.00M-0.03M-0.01M0.00M-0.02M-0.02M0.09M0.04M-0.00M-0.06M0.01M-0.02M-0.01M-0.00M-0.02M0.05M0.00M0.01M0.01M-0.00M
Change in Cash
0.43M0.97M-2.12M-2.19M1.07M0.22M-7.24M0.87M-5.23M7.58M-4.03M-2.90M3.01M0.25M0.54M-5.21M1.86M-0.58M2.38M-3.97M
Free Cash FlowFCF
0.43M0.96M-0.33M-0.45M1.10M0.25M0.87M-0.25M0.96M0.31M0.73M-0.70M-0.67M-0.08M-0.43M-0.31M0.23M0.28M-0.39M-0.37M
Net Cash FlowNCF
0.43M1.00M-2.11M-2.19M1.09M0.25M-7.33M0.83M-5.22M7.63M-4.04M-2.88M3.02M0.25M0.56M-5.27M1.86M-0.59M2.37M-3.97M